|
A
juggling act
Will the failure of Wockhardt Hospital's IPO deter investors
in the pharma industry? Not likely, as many players from other
industry verticals, as well as private equity investors continue
to add pharma and healthcare projects to their portfolios.
Viveka Roychowdhury analyses this juggling act
Ranbaxy
de-merges R&D
Ranbaxy Laboratories cleared the de-merger of it's new drug
discovery research (NDDR) unit into a subsidiary, Ranbaxy
Life Science Research (RLSRL).
Zydus
Cadila collaborates with Karo Bio of Sweden
Zydus Cadila and Karo Bio of Sweden, a drug discovery and
development company specialising in nuclear receptors, has
initiated a three-year strategic collaboration in the area
of drug discovery and development.
TMRC
announces £15 million investment
The Translational Medicine Research Collaboration (TMRC),
the venture bringing together one of the world's biggest pharmaceutical
companies with Scotland's finest medical research centres,
announced the second round of research projects to be funded
through the initiative.
Concept
pharmaceuticals rolls out an anti-ageing product
Concept pharma launched "Ajar", an anti-ageing product,
with its formulation based on Rasayan concept, validated with
modern scientific methods.
Mankind
enters into alliance with Roche
In an exclusive marketing agreement between Roche Diagnostics
and Mankind Pharma, it was decided that Mankind will undertake
marketing activities for 'Accu-Chek Go', a newly launched
blood glucose monitoring device by Roche, in India.
Zydus
Cadila firms up presence in oncology with Nudoxa
Zydus Cadila has introduced an NDDS product Nudoxa for the
treatment of various cancers.
Orchid
receives two US FDA approvals
Chennai-based pharma major, Orchid Chemicals and Pharmaceuticals
announced that it has received approval from the US FDA for
its Abbreviated New Drug Application (ANDA) for granisetron
hydrochloride tablets.
Wockhardt
enters the US market with Zithromax
Wockhardt will be launching Azithromycin tablets in the United
States.
Elder
Pharma introduces phytomega
Elder Pharma has announced the launch of its new product -
phytomega, a unique combination of Omega-3 fatty acids and
phytosterols which has been proven to reduce lipid levels
in the body.
Sun
Pharma buys Taro Pharma shares from Brandes
In a major development towards the future acquisition of Taro
Pharmaceutical, Sun Pharma went a step closer when it announced
a purchase of 3,712,557 shares, equivalent to an additional
9.4 percent stake in Taro.
Parsi
communities participates in the Avestagenome project
Avesthagen has initiated the first phase of the Avestagenome
project undertaking blood sample collection of the Parsi population
in Hyderabad, Navsari and Surat.
'21st
century belonged to life sciences'
BioAsia 2008, besides acting as a platform for business deals,
also brought out the message that there is a need for global
corporatisation. Arshiya Khan reports from Hyderabad
Micro
Therapeutic Research Labs launches CDM services
Chennai based contract research organisation, Micro Therapeutic
Research Labs (MTR) announced the launch of Clinical Data
Management (CDM) service.
IPC
and USP comes together in the 7th annual scientific meet
The 7th annual scientific summit of the Indian Pharmacopoeia
Commission (IPC) and US Pharmacopoeia (USP) commenced at the
Hyderabad International Convention Center from 6-7 Feb 2008.
Safexpress
and IIM organised 'CHAOS 2008'
Safexpress leaders in the supply chain and logistics industry
in collaboration with IIMA organised IIMA's cultural fest
'Chaos 2008'.
Changing
pharmaceutical challenges into opportunities
FICCI organised an international conference on 'Pharmaceuticals—Market
Prognosis-2012' from February 7 to 8, 2008 at hotel Hyatt
Regency, Mumbai.
Pharmexcil
organises 3-day INDIA-ASEAN Business Meet
The Pharmaceutical Export Council (Pharmexil), with the active
support of Ministry of Commerce and Industry, Government of
India organised a three-day INDIA-ASEAN Business Meet in Hyderabad
starting February 11.
Events
Brief
We
use relevant competitor prices as benchmarks
While many ayurvedic companies are finding it difficult to
export their products, Charak Pharma has emerged as one of
the largest ayurvedic product exporters. Dr Ram Shroff, Director,
Charak Pharma, reveals more about Charak's export policy to
Sachin Jagdale
|
